GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Techlead NPN PCL (BKK:TL-F) » Definitions » ROE %

Techlead NPN PCL (BKK:TL-F) ROE % : -121.70% (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Techlead NPN PCL ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Techlead NPN PCL's annualized net income for the quarter that ended in Mar. 2025 was ฿-215.84 Mil. Techlead NPN PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2025 was ฿177.36 Mil. Therefore, Techlead NPN PCL's annualized ROE % for the quarter that ended in Mar. 2025 was -121.70%.

The historical rank and industry rank for Techlead NPN PCL's ROE % or its related term are showing as below:

BKK:TL-F' s ROE % Range Over the Past 10 Years
Min: -146.51   Med: -2.03   Max: 12.36
Current: -11.49

During the past 13 years, Techlead NPN PCL's highest ROE % was 12.36%. The lowest was -146.51%. And the median was -2.03%.

BKK:TL-F's ROE % is ranked worse than
77.92% of 942 companies
in the Drug Manufacturers industry
Industry Median: 4.965 vs BKK:TL-F: -11.49

Techlead NPN PCL ROE % Historical Data

The historical data trend for Techlead NPN PCL's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Techlead NPN PCL ROE % Chart

Techlead NPN PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 12.36 -4.39 -146.51 -21.20

Techlead NPN PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.56 -35.03 -31.50 104.21 -121.70

Competitive Comparison of Techlead NPN PCL's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Techlead NPN PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Techlead NPN PCL's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Techlead NPN PCL's ROE % distribution charts can be found below:

* The bar in red indicates where Techlead NPN PCL's ROE % falls into.


;
;

Techlead NPN PCL ROE % Calculation

Techlead NPN PCL's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=-48.459/( (252.795+204.335)/ 2 )
=-48.459/228.565
=-21.20 %

Techlead NPN PCL's annualized ROE % for the quarter that ended in Mar. 2025 is calculated as

ROE %=Net Income (Q: Mar. 2025 )/( (Total Stockholders Equity (Q: Dec. 2024 )+Total Stockholders Equity (Q: Mar. 2025 ))/ count )
=-215.844/( (204.335+150.387)/ 2 )
=-215.844/177.361
=-121.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2025) net income data. ROE % is displayed in the 30-year financial page.


Techlead NPN PCL  (BKK:TL-F) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=-215.844/177.361
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-215.844 / 0)*(0 / 220.4115)*(220.4115 / 177.361)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*1.2427
=ROA %*Equity Multiplier
=N/A %*1.2427
=-121.70 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2025 )
=Net Income/Total Stockholders Equity
=-215.844/177.361
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-215.844 / -217.772) * (-217.772 / -106.688) * (-106.688 / 0) * (0 / 220.4115) * (220.4115 / 177.361)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9911 * 2.0412 * N/A % * 0 * 1.2427
=-121.70 %

Note: The net income data used here is four times the quarterly (Mar. 2025) net income data. The Revenue data used here is four times the quarterly (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Techlead NPN PCL ROE % Related Terms

Thank you for viewing the detailed overview of Techlead NPN PCL's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Techlead NPN PCL Business Description

Traded in Other Exchanges
Address
Ngamwongwan Road, 5th Floor, 50 Chulabhorn Science Research Center Building, Ladyao Subdistrict, Chatuchak District, Bangkok, THA, 10900
Techlead NPN PCL is a Thailand-based holding company that operates an agriculture business. The Company, through its subsidiary, Cannabiz Way Company Limited, operates the business of planting, extracting, processing, distributing, importing, exporting, and conducting all business related to hemp/marijuana raw materials. The Company, through its subsidiary, CBD Bioscience Company Limited, is engaged in the cultivation of hemp in greenhouses using the Evaporative Cooling System (EVAP), a closed farming system, which maintains the temperature at the appropriate level and works well in preventing epidemic disease in Nong Yuang, Wiang Nong Long, Lamphun.

Techlead NPN PCL Headlines

No Headlines